There’s no denying it; pharma is in its innovation era. The life sciences industry is already undergoing a massive revolution ...

Eran Harary, Senior Vice President of Global Early Clinical Development at Teva, said: “This collaboration will provide ...

The King’s Fund has appointed Siva Anandaciva, its current Chief Analyst, as Director of Policy, Events and Partnerships.

The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles Ardena has announced the full Good Manufacturing Practice (GMP) approval of its ...

The Medicine and Healthcare products Regulatory Agency (MHRA) has appointed Anthony Harnden, Professor of Primary Care in the Nuffield Department of Primary Care Health Sciences at the University of ...

Somerset NHS Foundation Trust has appointed Dr Rima Makarem as Chair Somerset NHS Foundation Trust has appointed Dr Rima Makarem, who has 15 years of experience working at board level in the NHS, as ...

The unseemly public health blockage is a symptom of communal constipation that is not shifting. The distribution of pharmaceuticals through the traditional means is abjectly failing as a result. And ...

We live in a world that increasingly demands answers – even when the questions, let alone the responses, are not an exact science. Make no mistake, the truth is complicated. Let’s take some clear and ...

In many ways UK pharma and the life sciences are radical outliers – transcending politics and thriving irrespective of the sitting administration. Indeed, the pandemic was a case study in how the ...

Pharma and the NHS. It’s the greatest and longest running soap opera, in which we are all playing varying roles. As in The Queen Vic, the Rovers Return and the Wolf Pack, there are lots of diferent ...

The era of equity – or striving for it – is not about rewriting history. Nor is it about righting history’s myriad wrongs. History has happened. History is toast. History is, erm, history – in the ...